About
Technology
Issues
FAQ
Links
Official Page
Endocrine therapy in prostate cancer: time for reappraisal of risks, benefits and cost-effectiveness?
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.